These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9855064)

  • 41. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men.
    Prins M; Sabin CA; Lee CA; Devereux H; Coutinho RA
    AIDS; 2000 Aug; 14(12):1829-37. PubMed ID: 10985321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C.
    Di Martino V; Thevenot T; Boyer N; Cazals-Hatem D; Degott C; Valla D; Marcellin P
    AIDS; 2002 Feb; 16(3):441-5. PubMed ID: 11834956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
    Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
    AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
    Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
    Virology; 1998 May; 244(2):504-12. PubMed ID: 9601518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suicide probability and psychological morbidity secondary to HIV infection: a control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HIV/HCV-seronegative injecting drug users.
    Grassi L; Mondardini D; Pavanati M; Sighinolfi L; Serra A; Ghinelli F
    J Affect Disord; 2001 May; 64(2-3):195-202. PubMed ID: 11313086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronic hepatitis C in HIV co-infected patients. Study of 55 cases with liver biopsy].
    Rubio Caballero M; Rubio Rivas C; Egido García R; Nogués Biau A
    Med Clin (Barc); 2004 Oct; 123(12):441-4. PubMed ID: 15498438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.
    Omland LH; Jepsen P; Weis N; Christensen PB; Laursen AL; Nielsen H; Krarup H; Sørensen HT; Obel N
    J Viral Hepat; 2010 Apr; 17(4):261-8. PubMed ID: 19709359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.
    Thomas DL; Shih JW; Alter HJ; Vlahov D; Cohn S; Hoover DR; Cheung L; Nelson KE
    J Infect Dis; 1996 Oct; 174(4):690-5. PubMed ID: 8843204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxis.
    Valencia J; Ryan P; Alvaro-Meca A; Troya J; Gutierrez J; Cuevas G; Moreno S
    AIDS; 2018 Jun; 32(9):1157-1163. PubMed ID: 29561294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years.
    Quintana M; del Amo J; Barrasa A; Pérez-Hoyos S; Ferreros I; Hernández F; Villar A; Jiménez V; Bolúmar F
    Haemophilia; 2003 Sep; 9(5):605-12. PubMed ID: 14511302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users.
    Lee HC; Ko NY; Lee NY; Chang CM; Ko WC
    J Formos Med Assoc; 2008 May; 107(5):404-11. PubMed ID: 18492625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
    Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
    Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
    Greub G; Ledergerber B; Battegay M; Grob P; Perrin L; Furrer H; Burgisser P; Erb P; Boggian K; Piffaretti JC; Hirschel B; Janin P; Francioli P; Flepp M; Telenti A
    Lancet; 2000 Nov; 356(9244):1800-5. PubMed ID: 11117912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis.
    Crum RM; Galai N; Cohn S; Celentano DD; Vlahov D
    Alcohol Clin Exp Res; 1996 Apr; 20(2):364-71. PubMed ID: 8730231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.
    Rossi C; Cox J; Cooper C; Martel-Laferrière V; Walmsley S; Gill J; Sapir-Pichhadze R; Moodie EE; Klein MB;
    AIDS; 2016 Jun; 30(9):1403-311. PubMed ID: 26859371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
    Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
    CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.